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Abstract Recent studies refute the commonly accepted, but 
untested, hypothesis that 7,10,13,16-22:4 and 7,10,13,16,19- 
22:5 are desaturated at position 4 by a microsomal acyl-CoA- 
dependent desaturase. The synthesis of 4,7,10,13,16,19- 
22:6 occurs via the following reaction sequence: 
24:6@ 4,7,10,13,16,19-22:6. The synthesis of 4,7,10,13,16-22:5 
from 7,10,13,16-22:4 takes place via an analogous pathway. 
According to these pathways the 24-carbon acids that are 
made in the endoplasmic reticulum move to a site for partial 
poxidation, which is most likely peroxisomes. The products 
of partial @oxidation, 4,7,10,13,16-22:5 and 4,7,10,13,16,19- 
22:6, then move back to the endoplasmic reticulum where 
they are used as substrates for membrane lipid biosynthesis. 
The ability of a fatty acid to serve as a substrate for continued 
peroxisomal @oxidation, versus its transfer out of perox- 
isomes for subsequent endoplasmic reticulum-associated 
esterification reactions, may be an important control for 
regulating membrane lipid fatty acid composition. Indeed, 
the revised pathways of polyunsaturated fatty acid biosynthe- 
sis imply that there is considerable intracellular movement 
and recycling of fatty acids between peroxisomes and the 
endoplasmic reticulum. In addition, these revised pathways 
require that two 18carbon and two 24-carbon acids are sub- 
strates for desaturation at position 6. Also, as linoleate and 
linolenate are metabolized, respectively, to 6,9,12,15,18-24:5 
and 6,9,12,15,18,21-24:6, three n-6 acids and three n-3 acids 
are substrates for malonyl-CoA dependent chain elongation. 
It remains to be determined how many microsomal enzymes 
are required to carry out these reactions and whether other 
ancillary enzymes are expressed in tissues whose membrane 
lipids accumulate very long-chain polyunsaturated acids with 
up to 36 carbon atoms.Sprecher, H., D. L. Luthria, B. S. 
Mohammed, and S. P. Baykousheva. Reevaluation of the 
pathways for the biosynthesis of polyunsaturated fatty acids. 
J. Lipid Res. 1995. 36: 2471-2477. 
7,10,13,16,19-22:5+ 9,12,15,18,21-24:5 + 6,9,12,15,18,21- 
Supplementary key words 
desaturation chain elongation polyunsaturated fatty acids 
peroxisomes microsomes acylation 
INTRODUCTION 
In animals, it is well established that dietary linoleate 
and linolenate are the respective precursors of long- 
chain n-6 and n-3 fatty acids. It has generally been 
assumed that endoplasmic reticulum-associated 6-, 5-, 
and 4-desaturases are required to metabolize linoleate 
and linolenate, respectively, to 4,7,10,13,16-22:5 and 
4,7,10,13,16,19-22:6. The fatty acids in these metabolic 
pathways are then esterified into acceptors to yield 
neutral lipids and phospholipids. In liver, the synthesis 
of glycerol-containing lipids is also localized primarily in 
the endoplasmic reticulum. The biosynthesis of polyun- 
saturated fatty acids and their subsequent esterification 
into acceptors may be viewed as two separate, but per- 
haps coupled, metabolic processes. The primary pur- 
pose of this review is to present evidence showing that 
the endoplasmic reticulum does not contain an acyl- 
CoA-dependent 4-desaturase. The biosynthesis of both 
4,7,10,13,16-22:5 and 4,7,10,13,16,19-22:6 and their sub- 
sequent esterification into acceptors requires intracellu- 
lar communication between the endoplasmic reticulum 
and a site for partial P-oxidation which is probably 
peroxisomes. 
DESATURASE ENZYMES 
In evaluating the validity of the pathways of polyun- 
saturated fatty acid biosynthesis, it is appropriate to 
briefly discuss what is known about the proteins that 
catalyze position-specific desaturation reactions. It is the 
reviewer's opinion that much of what we presume to 
know about these reactions is based primarily on infor- 
mation extrapolated from studies on the 9-desaturase 
that converts stearoyl-CoA to oleoyl-CoA. In 1965 
Schroepfer and Bloch (1) showed that 9-D-proton re- 
moval from stearic acid was the rate-limiting step in 
oleate synthesis. In 1974 Stritmatter et al. (2) purified a 
9-desaturase from rat liver and showed that it was a 
single polypeptide of 53,000 daltons containing one 
atom of non-heme iron. Desaturation of stearoyl-CoA 
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requires 0 2 ,  NADH, and three proteins that are cyto- 
chrome b5, cytochrome b5 reductase, and the de- 
saturase. The up-regulation in the hepatic synthesis of 
oleic acid, as induced by feeding a fat-free diet, is due to 
a 40-fold increase in the level of mRNA for the 9-de- 
saturase which has an in vivo half-life of about 4 h (3). It 
is now known that two different 9-desaturases are ex- 
pressed in tissue-specific ways in mice (4) and that the 
expression of stearoyl-CoA desaturase 1 in mouse liver 
is regulated by the type of dietary fat (5, 6). 
In 1981 Okayasu et al. (7) purified a 6-desaturase from 
rat liver and showed that cytochrome b5 and cytochrome 
b5 reductase were required to desaturate linoleate to 
6,9,12-18:3. The reconstituted system did not desaturate 
stearate, but it was not determined whether other sub- 
strates were desaturated at position 6 or whether this 
preparation could also introduce double bonds at posi- 
tion 5. Several different cell lines have the ability to 
desaturate fatty acids at position 5 but not at position 6 
(8, 9). It is this type of evidence that supports the 
hypothesis for position-specific acyl-CoA-dependent 5 
and 6 desaturases. However, Pugh and Kates (10) re- 
ported that 1-acyl-2-(8,11,14-eicosatrienoyl)-sn-glycero-3- 
phosphocholine was desaturated directly by rat liver 
microsomes to the arachidonatecontaining phos- 
pholipid. Stoffel and Ach (1 1) reported that 11,14-20:2, 
the chain elongation product of linoleate, was metabo- 
lized to 8,11,14-20:3 via a pathway that would require an 
8 desaturase. We showed that a number of acids with 
their first double bond at position 11 were desaturated 
at position 5, rather than at position 8 (12). Because 6, 
and particularly the 5-desaturase(s), have not been puri- 
fied, it is not known 1) whether cells contain more than 
one position-specific desaturase; 2) whether a given 
desaturase is totally position-specific; or 3)  whether a 
given protein can introduce double bonds into a variety 
of substrates as would be required for a 5-desaturase. 
There never was any firm evidence for an acyl-CoA- 
dependent 4desaturase. In 1960 Klenk and Mohrhauer 
(13) synthesized a series of carbon-14-labeled n-3 acids 
and administered them to rats. They isolated various 
fatty acids, degraded them, and on the basis of their 
results they proposed a number of biosynthetic path- 
ways, one of which required that 7,10,13,16,19-22:5 was 
converted to 4,7,10,13,16,19-22:6. However, when [l- 
14C]7,10,13,16-22:4 was incubated with rat liver and 
testes microsomes, it was not desaturated (14). When we 
incubated [1-14C]7,10,13,16,19-22:5 with rat liver mi- 
crosomes in the presence of ATP, CoASH, and NADH, 
it also was not desaturated (15). However, when malonyl- 
CoA and NADPH were included in the incubation, the 
substrate was converted into two radioactive products 
that were shown to be 9,12,15,18,21-24:5 and 
6,9,12,15,18,21-24:6. The latter compound could serve 
as a precursor for 4,7,10,13,16,19-22:6 if it was chain- 
shortened by two carbon atoms. When [ 1-I4C]- 
7,10,13,16,19-22:5, [3-14C]9, 12,15,18,21-24:5, and [3-I4C]- 
6,9,12,15,18,21-24:6 were incubated with rat hepato- 
cytes, all three substrates were metabolized to yield 
[ 1-14C]4,7,10,13,16,19-22:6 which was esterified into cel- 
lular phospholipids. Studies analogous to these have 
shown that 7,10,13,16-22:4 is metabolized to 
4,7,10,13,16-22:5 via an identical pathway (16). 
ROLE OF PEROXISOMES 
The above studies show that 7,10,13,16-22:4 and 
7,10,13,16,19-22:5 are the respective precursors of 
4,7,10,13,16-22:5 and 4,7,10,13,16,19-22:6 but their syn- 
thesis requires intracellular communication between 
the endoplasmic reticulum and a site for partial fhxida- 
tion which is most likely peroxisomes. It is well docu- 
mented that peroxisomes function to partially &oxidize 
fatty acids and the chain-shortened products may then 
move to the mitochondria where the process is com- 
pleted (17, 18). It is also well established that a variety 
of polyunsaturated fatty acids are partially P-oxidized 
with the subsequent esterification of chainshortened 
metabolites into membrane lipids. We elected to use 
[3-14C]7,10,13,16-22:4 as amodel substrate to study what 
controls the partial P-oxidation-acylation process. The 
rationale for using this acid is based on the observation 
that when it was fed to rats raised on a diet devoid of 
fat, it was primarily metabolized to yield esterified 
arachidonate (19). When [3-14C]7,10,13,16-22:4 was in- 
cubated with fibroblasts from control patients, it was 
metabolized to yield esterified arachidonate. Con- 
versely, when it was incubated with fibroblasts from 
patients with Zellweger’s disease, who lack peroxisomes, 
it was not possible to detect esterified arachidonate (20). 
When we incubated [ 1-14C]22:4 (n-6) with peroxisomes, 
its rate of &oxidation, as measured by the generation of 
acid-soluble radioactivity, was independent of mi- 
crosomes and l-acyl-sn-glycero-3-phosphocholine ( l- 
acyl-GPC). With [3-14C]7, 10,13,16-22:4 as substrate, the 
addition of 1-acyl-GPC to peroxisomes depressed the 
production of acid-soluble radioactivity. When mi- 
crosomes were also included in the incubation, the rate 
of production of acid-soluble radioactivity was further 
depressed. When the phospholipids were isolated from 
both types of incubation, about 90% of the esterified 
radioactivity was arachidonate with the remaining 10% 
being unmetabolized substrate. A puzzling finding was 
the observation that when peroxisomes were incubated 
with 1-acyl-GPC, some substrate and arachidonate were 
esterified into the acceptor. The findings suggested that 
peroxisomes contained acyl-CoA: 1-acyl-GPC acyltrans- 














feme activity. When Nycodenz-purified peroxisomes 5,8,11,1420:4 "+-a 
ing NADPH-cytochrome-c reductase activity, the mi- 
were assayed for microsomal contamination by measur- 
crosomal contamination in peroxisomes correlated ex- 
actly with the percentage of contamination found when 0 0 
0 
"---"+-- 
the specific activity of arachidonoyl-CoA: l-acyl-GPC 
acyltrksferase was .measured in peroxisomes and mi- 
crosomes (21, 22). The esterification activity observed 
in peroxisomes is thus due to small amounts of microso- 
mal contamination. It has been shown by Das, Horie, 
and Hajra (23) that peroxisomes are contaminated with 
small amounts of microsomes even when they are sub- 
jected to double Nycodenz gradient centrifugation. Our 
results thus show that when a microsomal metabolite, 
such as 22:4(n-6), moves to peroxisomes for partial 
Boxidation, the chain-shortened product must move 
back to the endoplasmic reticulum for esterification. 
Indeed, the preferred metabolic fate of arachidonate 
when it was produced via boxidation was to move out 
of peroxisomes for esterification in the endoplasmic 
reticulum rather than to serve as a substrate for contin- 
ued poxidation (21). Two types of processes may con- 
tribute to this type of intracellular regulation. First, rates 
of acylation of 7,10,13,16-22:4 and 5,8,11,14-20:4 into 
l-acyl-GPC by microsomes from rats fed clofibrate were, 
respectively, 18 and 159 nmols/min per mg of protein 
(22). Arachidonate is thus a much better substrate for 
esterification than is 22:4( n-6). Secondly, arachidonate 
is a relatively poor substrate for peroxisomal P-oxidation 
(21, 24). Until recently it was generally accepted that 
3,6,9,12-18:4 would be produced after one cycle of 
arachidonate ()oxidation. Tserng and Jin (25) reported 
that in mitochondria the double bond at position 5 in a 
number of monounsaturated fatty acids was directly 
removed via a nudeotidedependent 5-reductase. This 
pathway has now been revised to show that it requires 
NADPHdependent 2,Pdienoyl reductase and a new 
enzyme, A3*5,Az>4-dienoyl-CoA isomerase (26, 27) that 
has been purified from rat liver mitochondria (28, 29). 
Recently we showed that the removal of both odd-num- 
bered double bonds, during peroxisomal P-oxidation of 
arachidonate, also requires 2,4-dienoyl-CoA reductase 
and A2.4dienoyl-CoA isomerase (30). As shown in 
Fig. 1, one complete cycle of arachidonate wxidation 
yields 6,9,12-18:s. The 2-truns-8,11,14-20:4 may serve as 
an intermediate in the boxidation cycle. Alternatively, 
it may be reduced to 8,11,14-20:3 via a nucleotidede- 
pendent 2-trans-acyl-CoA reductase which was shown by 
Dommes et al. (31) to be a different protein than is 
NADPHdependent 2,4dienoyl-CoA reductase. Horie, 
Suzuki, and S u p  (32) have shown that peroxisomes 
have an acetyl-CoAdependent chainelongation system. 
Reduction of 2-trunr-8,11,1420:4 to 8,11,1420:3 is the 
last step in chain elongation. The above results show that 
2 




Fig. 1. A possible pathway for the peroxisomal Poxidation of arachi- 
donic acid as elucidated in reference 30. The enzymes in this proposed 
pathway are fatty acid oxidase (l),  the trifunctional enzyme with A3, 
A*-enoylCoA isomerase activity (2), A33, A5,4dienoylCoA isomerase 
(3), NADPHdependent 2,Mienoyl-CoA reductase (4), the trifunc- 
tional enzyme (5 and 6), and an NADPHdependent 2-trancacylCoA 
reductase (7). 
when the microsomal metabolite 22:4(n-6) enters per- 
oxisomes, it is readily boxidized but it is a relatively poor 
substrate for endoplasmic reticulum-associated esterifi- 
cation reactions. As soon as arachidonate is produced, 
it is preferentially transported out of peroxisomes, via 
some unknown pathway, for rapid esterification, rather 
than serving as a substrate for continued P-oxidation. 
REGULATlON OF PARTIAL FOXIDATION 
The above data show that intracellular communica- 
tion exists between peroxisomes and the endoplasmic 
reticulum for a partial bxidationesterification cycle. 
The revised pathways of polyunsaturated fatty acid bio- 
synthesis, as shown in Fig. 2, raise several new questions 
about the regulation of this partial P-oxidation-acylation 
process. The pathways imply that linoleate and li- 
nolenate are metabolized, respectively, to 24-carbon 
acids in the endoplasmic reticulum. In theory, any fatty 
acid can be removed from these pathways for esterifica- 
tion into membrane lipids. If 24carbon acids are esteri- 
fied into membrane lipids in the endoplasmic reticulum, 
it would in essence curtail their movement to perox- 
isomes for partial poxidation. When we incubated the 
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Fig. 4. Revised pathways for the biosynthesis of both 4,7,10,19,16docosapentaenoic acid and 4,7,10,13,16,19- 
docosahexaenoic acid. The solid arrows denote reactions that take place in the endoplasmic reticulum. The 
dashed arrows show acids that are known substrates for partial Poxidation followed by esterification of 
chain-shortened products into membrane lipids. 
CoASH derivatives of 204(n-6), 22:4(n-6), 24:4(n-6), 
and 24:5(n-6) with rat liver microsomes, their rates of 
acylation into l-acyl-GPC were, respectively, 159, 18, 
134,1, and 1 nmol/min per mg of protein. As 24carbon 
acids were, in essence, not esterified, they may prefer- 
entially move to peroxisomes for partial P-oxidation. 
Although neither 24:4(n-6) nor 24:5(n-6) was readily 
esterified, there are possible important differences as to 
how their partial P-oxidation products, i.e., 7,10,13,16- 
22:4 and 4,7,10,13,16-22:5, are processed. The microso- 
mal studies show that 4,7,10,13,16-22:5 is a better sub- 
strate for acylation than is 7,10,13,16-22:4. When 
7,10,13,16-22:4 is produced from 9,12,15,1824:4, its 
continued &oxidation to 5,8,11,1420:4 requires only 
the enzymes for saturated fatty acid degradation. Con- 
versely, when 4,7,10,13,16-22:5 is produced via boxida- 
tion of 6,9,12,15,18245, its continued boxidation to 
5,8,11,1420:4 requires removal of the double bond at 
position 4. In general, peroxisomal &oxidation of fatty 
acids with their first double bond at position 4 proceeds 
at a slow rate (24,30), perhaps because both 2,Uienoyl- 
CoA reductase and the trifunctional enzyme with A3, 
A2-enoylCoA isomerase activity are required (33). The 
studies with 22:4(n-6) and 20:4(n-6) as well as with 
other substrates lead to a working hypothesis suggesting 
that there is an inverse relationship between rates of 
peroxisomal P-oxidation and the esterification of fatty 
acids into acceptors in the endoplasmic reticulum. Com- 
petition for endoplasmic reticulum-associated acylation 
reactions, versus continued peroxisomal boxidation, 
may be an important in vivo type of control in regulating 
membrane lipid fatty acid composition. 
EXTRAHEPATIC PATHWAYS 
The preceding discussion focuses on liver metabo- 
lism. It is appropriate to ask two other questions. First, 
do extrahepatic tissues express a microsomal acyl-CoA- 
dependent Pdesaturase? Wang and Anderson (34) re- 
ported that radioactive 24:5(n-3) and 24:6(n-3) were 
produced when labeled n-3 acids were metabolized to 
22:6(n-3) in retinal pigment epithelium. The results 
suggest that 24-carbon acids are obligatory intermedi- 
ates in 22:6 (n-3) biosynthesis. In their recent extensive 
studies on n-3 fatty acid metabolism, Moore et al. (35) 
reported that normal human fibroblasts metabolized 
[ 1-14C]18:3(n-3) to labeled 22:6(n-3), 24:5(n-3), and 
24:6(n-3). Conversely, fibroblasts from patients with 
Zellweger’s disease metabolized [ 1-%]18:3(n-3) to 
24:5(n-3) and 24:6(n-3) but not to 22:6(n-3). In a 
similar way, [3-14C]-labeled 22:5(n-3), 24:5(n-3), and 
24:6(n-3) were all metabolized to 22:6(n-3) in control, 
but not Zellweger’s fibroblasts. These results also docu- 
ment that peroxisomes are required for 22:6(n-3) bio- 
synthesis. When 2 pM [3-I4C]22:5(n-3) was incubated 
with increasing amounts of unlabeled 24:5(n-3) or 
24:6(n-3), there was a dose-dependent decrease in the 
production of labeled 22:6(n-3). The results show that 
22:5(n-3) was not desaturated directly to 22:6(n-3) but 














rather that the labeled 22:5(n-3) was metabolized to 
24-carbon (n-3) acids. As the incubations contained 
unlabeled 24carbon acids, the specific activity of 
22:6(n-3) precursors was diluted leading to the synthesis 
of esterified 22:6(n-3) with a lower specific activity. 
Second, what major differences exist for regulating fatty 
acid biosynthesis and the esterification of long-chain 
fatty acids into liver versus extrahepatic membrane lip 
ids? The pathways in Fig. 2 imply that 24:5(n-6) and 
24:6(n-3) are in essence end metabolites of microsomal 
metabolism in liver. These acids then move to perox- 
isomes where they are chain shortened, respectively, to 
22:5(n-6) and 22:6(n-3), followed again by their trans- 
fer back to the endoplasmic reticulum for esterification. 
Membrane lipids from many tissues contain small 
amounts of very long-chain polyunsaturated fatty acids 
with 24-36 carbon atoms (36,37). Clearly, then, in many 
tissues 24carbon fatty acids are not end metabolites of 
microsomal metabolism but rather precursors for fami- 
lies of very long-chain acids which, in turn, are accepted 
by enzymes that synthesize phospholipids and are not 
just moved to peroxisomes for partial boxidation fol- 
lowed by esterification of chain-shortened metabolites. 
CHAIN LENGTH SPECIFIC ENZYMES 
Although the absence of a microsomal acyl-CoAde- 
pendent 4desaturase is of considerable interest, this 
finding has further ramifications relative to the regula- 
tion of fatty acid biosynthesis. First, do microsomes 
contain chain length position 6desaturases? As shown 
in Fig. 2 the biosynthesis of 24:5(n-6) and 24:6(n-3) 
requires that two substrates in each pathway are desatu- 
rated at position 6. In a series of competitive substrate 
studies, no clear evidence was obtained for chain length- 
specific acyl-CoA-dependent 6desaturases (38). It is gen- 
erally accepted that desaturation of linoleate and li- 
nolenate, at position 6, is the rate-limiting step in 
arachidonate and 20:5(n-3) biosynthesis (39, 40). It 
would seem unlikely that an enzyme catalyzing a rate- 
limiting step could be used again to desaturate 24:4(n-6) 
and 24:5(n-3) at position 6. Second, how many chain- 
elongating enzymes are present in liver microsomes, 
and are different forms expressed in extrahepatic tissues 
that synthesize very long-chain fatty acids? In a recent 
review Cinti et al. (41) summarize the evidence suggest- 
ing that microsomes contain two different malonyl-CoA- 
dependent condensing enzymes: one of which uses satu- 
rated primers while the other accepts unsaturated 
acyl-CoAs. The respective bketoacyl-CoAs are then pre- 
sumably channeled into a common set of enzymes to 
complete the chainelongation processes. According to 
the pathways depicted in Fig. 2, three fatty acids in each 
pathway are chain-elongated and two of these reactions 
take place in sequence. Again, it would seem highly 
unlikely that a single hepatic condensing enzyme or 
chainelongating system could be regulated to accept six 
different substrates. 
PARTIAL gOXIDATION AS AN ANABOLIC 
PROCESS 
It has long been recognized that long-chain fatty acids 
are partially P-oxidized with the esterification of chain- 
shortened metabolites into membrane lipids. The physi- 
ological relevance of this process was never apparent. 
According to the pathways depicted in Fig. 2, the partial 
P-oxidation of 6,9,12,15,18-24:5 and 6,9,12,15,18,21- 
24:6, respectively, to 4,7,10,13,16-22:5 and 
4,7,10,13,16,19-22:6 is, in essence, a Poxidation step 
that is used in an anabolic mode. Indeed, the partial 
boxidation process may play an important role in regu- 
lating how a variety of fatty acids are processed. As 
shown in Fig. 1,6,9,12-18:3 is produced after one cycle 
of arachidonate boxidation. It remains to be deter- 
mined whether the preferred metabolic fate of 6,9,12- 
18:3 is continued boxidation or whether, in part, it 
moves to the endoplasmic reticulum for conversion 
back to arachidonate. Several studies suggest that chain- 
shortened products of boxidation may have a variety of 
possible anabolic fates. The a-subunit of transducin, a 
retinal G protein, contains esterified 14:2(n-6), a find- 
ing that implies that this chain-shortened catabolite of 
n-6 fatty P-oxidation has an anabolic fate (42). Gordon 
et al. (43) reported that when tritium-labeled 20:4(n-6) 
was incubated with fibroblasts, 4,7,10-16:3 accumulated 
in the medium of control cells but not of those obtained 
from patients with Zellweger’s disease. Hansen, Jensen, 
and von Wettstein-Knowles (44) found that arachi- 
donate was converted to linoleate in rats fed a diet 
devoid of fat. Three cycles of arachidonate pxidation 
can lead to the production of 14:2(n-6) which, when fed 
to rats, is metabolized to 18:2(n-6) (45). 
n-3 ACIDS VERSUS n-6 ACIDS 
Differences in structure between n-3 acids and n-6 
acids also play an important role in dictating how fatty 
acids are processed intracellularly. Membrane lipids 
generally contain large amounts of 22:6(n-3) but only 
low levels of 22:5(n-6). This type of compositional dif- 
ference could be explained if microsomal reaction rates 
for converting 20:5(n-3) to 24:6(n-3) were more rapid 
than for the conversion of 20:4(n-6) to 24:5(n-6). How- 














ever, individual reaction rates for desaturation and 
chain elongation of analogous n-3 and n-6 fatty acids 
were similar (16,38). Reaction rates for acylation of n-3 
versus n-6 acids into 1-acyl-GPC were also similar (46). 
When [3-14C]22:4(n-6) was injected into the tail vein of 
rats fed Purina chow, 96% of the esterified radioactivity 
in liver phospholipids was arachidonate with the remain- 
der being unmetabolized substrate. Conversely, when 
[3-14C]22:5(n-3) was injected, 20, 56, and 24%, respec- 
tively, of the esterified radioactivity was 20:5(n-3), 
22:5(n-3), and 22:6(n-3) (47). Clearly, there are differ- 
ences as to how n-3 versus n-6 fatty acids are processed 
within the cell that cannot be explained by reaction rates 
within any single subcellular compartment. 
CONCLUSION 
Prior to the discovery that microsomes do not contain 
a Mesaturase, the synthesis of polyunsaturated fatty 
acids and their subsequent esterification into mem- 
brane lipids could be viewed as a process confined 
primarily to the endoplasmic reticulum. Why mi- 
crosomes desaturate fatty acids at positions 9, 6, and 5, 
but not at position 4, remains to be explained. This 
review has pointed out that considerable recycling of 
fatty acids between peroxisomes and microsomes may 
take place. In theory, any long chain n-3 or n-6 fatty 
acid could be recycled many times. As long as any n-6 
acid retains two double bonds, or an n-3 acid three 
double bonds, these putative peroxisomal catabolites 
have the potential of moving back to the endoplasmic 
reticulum for conversion, via chain elongation and de- 
saturation reactions, back to 20-, 22-, or 24-carbon un- 
saturated acids. In this regard, rate-limiting reactions in 
a metabolic sequence, such as desaturation of linoleate 
by a Mesaturase, must be reevaluated because even 
when arachidonate is degraded to 14:2(n-6) or 
16:3(n-6) (21), these chain-shortened compounds are 
converted back to arachidonate without using a 6-de- 
saturase (45, 48). 
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